Dermatologists tell ELLE FDA panel backed six of 19 restricted peptides
The July 2026 advisory committee vote covers only compounded injectable peptides and is a recommendation, not an approval, the physicians interviewed stress.
DO
By Daniel Okafor · Regulatory Correspondent
Sep 29 08:09 ETSource: ELLE
The wire
- 01ELLE reports that HHS moved this summer to revisit distribution restrictions on a batch of peptides, and that a July 2026 FDA advisory committee recommended six of the 19 peptides restricted in 2023.
- 02Compounders and prescribers fielding patient questions should note the quoted dermatologists' point that the easing applies to compounded injectables, not topical peptide cosmetics.
- 03The vote is advisory only; FDA has not acted, and the physicians say recommendation does not establish that the peptides are safe or effective.
From the source
Read at elle.comBefore You Try Injectable Peptides, Here’s What the Experts Want You to Know
Every item on this page was chosen by an ELLE editor. We may earn commission on some of the items you choose to buy.
